Spain Pharmaceuticals and Healthcare Report Q2 2014

Business Monitor International
March 26, 2014
101 Pages - SKU: BMI5222040
Countries covered: Spain

Spain Pharmaceuticals and Healthcare Report Q2 2014

BMI View: Despite the Spanish economy returning to growth in 2014, the country's pharmaceuticals andhealthcare sectors show no sign of following suit. The Spanish government's ongoing cash flow troublesand aggressive fiscal austerity measures, which focus heavily on cost containment in the healthcare sector,will continue to negatively impact pharmaceutical companies operating in Spain.

Headline Expenditure Projections

Pharmaceuticals: EUR24.09bn (US$31.79bn) in 2013 to EUR22.81bn (US$28.97bn) in 2014; -5.3% inlocal currency terms and -8.9% in US dollar terms.

Healthcare: EUR98.71bn (US$130.30bn) in 2013 to EUR98.57bn (US$125.19bn) in 2014; -0.1% inlocal currency terms and -3.9% in US dollar terms.



More Prescription Drugs reports by Business Monitor International

Pharmaceuticals and Healthcare Report - Russia Q4 2104 by Business Monitor International
BMI View: Russia's cooling of relations with the West is putting pressure on foreign investment in thecountry. With the EU and the US applying further ...
Pharmaceuticals and Healthcare Report - Greece Q4 2104 by Business Monitor International
BMI View: The pharmaceutical and healthcare industry in Greece will continue to contract over theremainder of 2014. The government will seek to reduce public spending ...
Pharmaceuticals and Healthcare Report - Finland Q4 2104 by Business Monitor International
BMI View: An ageing population and the subsequent increased consumption of high-value prescriptionmedicines for the treatment of long-term illnesses will place a greater strain on ...
Pharmaceuticals and Healthcare Report - Oman Q4 2014 by Business Monitor International
BMI View: Despite its small size in comparison with other GCC countries, Oman will remain an attractivemarket to multinational pharmaceutical companies due to the high ...
See all reports like this >>

More Spain Prescription Drugs reports

Pharmaceuticals and Healthcare Report - Spain Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - Spain Q4 2014BMI View: Despite the Spanish economy returning to growth in 2014 and picking up steam heading into2015, we ...
Pharmaceuticals and Healthcare Report Q3 2014 - Spain by Business Monitor International
Spain Pharmaceuticals and Healthcare Report Q3 2014BMI View: The weakened Spanish economy and the government's ongoing multi-faceted strategy to containexpenditure on prescription medicines by targeting ...
PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022 by GlobalData
PharmaPoint: Schizophrenia - 5EU Drug Forecast and Market Analysis to 2022SummarySchizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core ...
Pharmaceuticals in Spain: ISIC 2423 by Euromonitor International
Pharmaceuticals in Spain: ISIC 2423Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!